Earnings Call · Q2 FY2021·2021-08-05

Q2 21EPS -30.30%·Rev n/aQ1 21EPS -10.00%·Rev n/aQ4 20EPS -100.00%*·Rev n/aQ3 20EPS +85.29%·Rev n/a⚠ consensus missing

CYTOKINETICS INC CYTK

Diane Weiser — Vice President, Investor Relations

Robert Blum — President and Chief Executive Officer

Fady Malik — Executive Vice President, Research and Development

Andrew Callos — Chief Commercial Officer

Stuart Kupfer — Senior Vice President, Clinical Development and Medical Affairs

Robert Wong — Chief Financial Officer

Ching Jaw — Chief Financial Officer

+5.2%1d on move date+5.1% vs SPY3d+5.6%5d+7.2%

Research tier

Behavioral profile computed for 7 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CYTK calls or request research access.

More CYTK calls Browse calls Request research access